As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

The global insulin analog market size was valued at USD 16.99 billion in 2024 and is predicted to hit around USD 25.29 ...

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

CVS settles insulin dispensing case for $38M over improper billing to Medicare, Medicaid and federal health programs from 2010 to 2020.

CVS has settled a lawsuit for $37.76 million over claims of over-dispensing insulin pens and fraudulent billing.

Weight-loss expert Professor Franklin Joseph has warned that social media has fuelled a rise in dangerous counterfeit ...

Dolfin is a well-established, diversified distributor with broad reach across healthcare, hospitals, emergency services, and consumers provides strong potential for VIVI products to gain ...

In a settlement that echoes like a warning shot across the pharmacy industry, CVS Pharmacy Inc. agreed Tuesday to pay $37.76 million to resolve federal allegations that it spent a decade ...

CVS Health ( CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens.

The jab is also known as Godzilla or Triple G, and authorities have warned that social media has become a “wild west” for ...